MariMed Inc. Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Subsequent Events (Details Narrative)

Subsequent Events (Details Narrative) - USD ($)		1 Months Ended			3 Months Ended	12 Months Ended
Subsequent Events (Details Narrative) - USD ($)	Feb. 29, 2020	Feb. 29, 2020	Jan. 31, 2020	Dec. 31, 2018	Mar. 30, 2020	Dec. 31, 2019	Dec. 31, 2018
Equity in loss of investments						$ (30,334,503)	$ (43,221)
Repayment of notes							700,000
Debt conversion amount							$ 1,904,316
Common stock, shares subscribed but unissued				97,136		3,236,857	97,136
20M Debentures [Member]
Warrants to purchase shares of common stock				324,675		850,000	324,675
Debt principal amount						$ 20,000,000
Amortization payments						$ 1,298,000	$ 91,000
Number of common stock issued during period						3,004,131
20M Debentures [Member] \| Minimum [Member]
Warrant exercise price per share				$ 3.50		$ 3.00	$ 3.50
Promissory Note [Member] \| Minimum [Member]
Conversion price per share				$ 0.65			$ 0.65
Promissory Notes [Member]
Number of common stock shares exchanged				1,568,375
Debt principal amount						$ 1,047,000
Repayment of notes							$ 700,000
Debt conversion amount				$ 1,075,000			$ 2,500,000
Accrued interest						$ 7,590,000
Number of common stock issued during period						2,435,116	3,827,373
Common stock, shares subscribed but unissued				79,136		0	79,136
20M Debentures Holders [Member]
Subscription outstanding, shares						3,004,131
Accredited Investor [Member]
Debt instrument interest rate						10.00%
Employees [Member]
Number of common stock issued during period						141,546
Common stock, shares subscribed but unissued						32,726
CEO [Member]
Number of common stock shares exchanged						200,000
Subsequent Event [Member]
Debt principal payment	$ 100,000	$ 100,000
Number of common stock issued during period					3,236,857
Subsequent Event [Member] \| 20M Debentures [Member]
Number of common stock shares exchanged			3,555,859
Debt instrument interest rate	6.50%	6.50%
Debt maturity date description		Matures one year from issuance
Additional convertible debenture	$ 1,000,000	$ 1,000,000
Issuance of debt discount percentage		6.50%
Debt principal amount			$ 20,000,000
Debt conversion amount			1,000,000
Accrued interest			$ 205,000
Conversion price per share			$ 0.34
Subsequent Event [Member] \| Promissory Notes [Member]
Debt principal amount	3,000,000	$ 3,000,000
Promissory notes	9,400,000	9,400,000
Subsequent Event [Member] \| Accredited Investor [Member]
Loaned amount	$ 1,200,000	$ 1,200,000
Debt instrument interest rate	10.00%	10.00%
Subsequent Event [Member] \| Exchange Agreement [Member] \| Two Institutional Shareholders [Member]
Loaned amount	$ 4,417,500	$ 4,417,500
Number of common stock shares exchanged		4,903,333
Debt instrument interest rate	16.50%	16.50%
Debt maturity date description		Maturing in August 2021, with a right to extend the maturity date through February 2022 upon payment of an extension fee.
Subsequent Event [Member] \| Securities Purchase Agreement [Member] \| 20M Debentures [Member]
Additional convertible debenture	$ 1,000,000	$ 1,000,000
Warrants to purchase shares of common stock	180,000	180,000
Warrant exercise price per share	$ 0.75	$ 0.75
Subsequent Event [Member] \| 11.5M Note [Member]
Debt maturity date description	Due on or before April 30, 2020
Subsequent Event [Member] \| 11.5M Note [Member] \| Promissory Note [Member]
Debt maturity date description	Due on June 15, 2020
Debt principal amount	$ 11,500,000	$ 11,500,000
Debt interest rate during period	15.00%
Subsequent Event [Member] \| 11.5M Note [Member] \| Promissory Note [Member] \| Minimum [Member]
Amortization payments	$ 3,000,000
Repayment of notes	2,300,000
Subsequent Event [Member] \| 10M Note [Member] \| Promissory Note [Member]
Debt principal amount	$ 10,000,000	$ 10,000,000
GenCanna Bankruptcy Filing [Member]
Outstanding receivable balance						$ 29,000,000
Unearned revenue						$ 4,200,000